40 results
8-K
EX-10.2
NXEN
Nexien Biopharma, Inc.
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
information sent to shareholders). In the event of any taking by the Borrower of a record of its shareholders for the purpose of determining shareholders who … , or for the purpose of determining shareholders who are entitled to vote in connection with any proposed sale, lease or conveyance of all
8-K
EX-10.1
l1f907f1apr
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
8-K
EX-10.3
bt4lknmy2al3f
21 Jan 22
Entry into a Material Definitive Agreement
1:04pm
DEF 14C
qwwpm8gundbz29
8 Mar 19
Information statement
9:35am
8-K
EX-99.1
wz37w4l7dox
26 Feb 19
Nexien BioPharma to File Pre-IND Meeting Request with the FDA
8:55am
8-K
EX-99.1
zt5qnmm
5 Nov 18
Regulation FD Disclosure
5:17pm
8-K
EX-99.1
717a dtf95od99d3mss
30 Oct 18
Nexien BioPharma Acquires Princeton-Based CRx Bio and Announces Additions to Senior Management
6:18am
8-K
EX-99.1
yolz8a58
19 Oct 18
Announces Symbol Change to NXEN
6:15am
8-K
EX-99.1
zr9aw1 o7
1 Oct 18
Amendments to Articles of Incorporation or Bylaws
1:14pm